Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lung cancer Patients' Real-World data to guide future treatments

NCT ID NCT06726720

Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Aug 28, 2026 · Updated 3 times

Summary

This study observes 300 adults with non-small cell lung cancer who are starting approved AstraZeneca drugs in routine care. Researchers will track how long patients stay on treatment and how well the drugs work in real-world settings. The goal is to gather practical insights, not to test new therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2024

Expected to finish

Jun 2032

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study will be carried out with hospital and / or private clinics / hospitals (pulmonologist, medical oncologists) specialized in the treatment of patients with NSCLC in France and in Germany or any other participating countries afterwards.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (≥ 18 years old) * Patients with histologically or cytologically proven NSCLC * Patients initiated with approved drugs developed by AZ or as part of an AZ alliance at the time of the enrollment or within the previous three weeks. * Informed patients who consent to participate in the study as per local regulations. Exclusion Criteria: * Patients participating in an interventional clinical trial for NSCLC\* \* with the exception on low-interventional studies (RIPH2) where the intervention does not involve the NSCLC treatment * Patients already enrolled in another module of the cohort in UMBREALUNG * Patients under safeguard of justice, curatorship or guardianship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Real world multi-cohort study of patients with non-small cell lung cancer (NSCLC) initiating approved drugs developed by az or as part of an az alliance are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Real world multi-cohort study of patients with non-small cell lung cancer (NSCLC) initiating approved drugs developed by az or as part of an az alliance

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    70 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Research Site

    RECRUITING

    Aix-en-Provence, 13100, France

  • Research Site

    RECRUITING

    Angers, 49933, France

  • Research Site

    RECRUITING

    Aurillac, 15000, France

  • Research Site

    RECRUITING

    Auxerre, 89000, France

  • Research Site

    RECRUITING

    Avignon, 84918, France

  • Research Site

    NOT_YET_RECRUITING

    Bezannes, 51430, France

  • Research Site

    NOT_YET_RECRUITING

    Béziers, 34500, France

  • Research Site

    RECRUITING

    Blois, 41016, France

  • Research Site

    RECRUITING

    Bordeaux, 33000, France

  • Research Site

    RECRUITING

    Bourg-en-Bresse, 01012, France

  • Research Site

    NOT_YET_RECRUITING

    Caen, 14052, France

  • Research Site

    RECRUITING

    Carcassonne, 11010, France

  • Research Site

    RECRUITING

    Chalon Sur Sa Ne, 71321, France

  • Research Site

    RECRUITING

    Chambéry, 73000, France

  • Research Site

    RECRUITING

    Châteauroux, 36019, France

  • Research Site

    RECRUITING

    Créteil, 94000, France

  • Research Site

    RECRUITING

    Dieppe, 76202, France

  • Research Site

    RECRUITING

    Dinan, 22100, France

  • Research Site

    RECRUITING

    Dreux, 28102, France

  • Research Site

    RECRUITING

    Epagny METZ Tessy, 74370, France

  • Research Site

    RECRUITING

    Fort de France Cedex, 97200, France

  • Research Site

    RECRUITING

    Le Coudray, 28630, France

  • Research Site

    RECRUITING

    Limoges, 87000, France

  • Research Site

    RECRUITING

    Lyon, 69437, France

  • Research Site

    RECRUITING

    Marseille, 13003, France

  • Research Site

    RECRUITING

    Marseille, 13285, France

  • Research Site

    RECRUITING

    Marseille, 13915, France

  • Research Site

    RECRUITING

    Meaux, 77100, France

  • Research Site

    NOT_YET_RECRUITING

    Metz, 57000, France

  • Research Site

    RECRUITING

    Metz, 57070, France

  • Research Site

    RECRUITING

    Mulhouse, 68100, France

  • Research Site

    RECRUITING

    N MES, 30029, France

  • Research Site

    RECRUITING

    Nancy, 54100, France

  • Research Site

    RECRUITING

    Nantes, 44200, France

  • Research Site

    RECRUITING

    Neuilly-sur-Seine, 92200, France

  • Research Site

    RECRUITING

    Nice, 06000, France

  • Research Site

    RECRUITING

    Perpignan, 66000, France

  • Research Site

    NOT_YET_RECRUITING

    Reims, 51726, France

  • Research Site

    NOT_YET_RECRUITING

    Rouen, 76000, France

  • Research Site

    RECRUITING

    Saint-Brieuc, 22000, France

  • Research Site

    RECRUITING

    Saint-Etienne, 42100, France

  • Research Site

    RECRUITING

    Saint-Herblain, 44800, France

  • Research Site

    RECRUITING

    Saint-Priest-en-Jarez, 42271, France

  • Research Site

    RECRUITING

    Strasbourg, 67000, France

  • Research Site

    RECRUITING

    Suresnes, 92151, France

  • Research Site

    RECRUITING

    Toulouse, 31076, France

  • Research Site

    RECRUITING

    Troyes, 10000, France

  • Research Site

    RECRUITING

    Valenciennes, 59300, France

  • Research Site

    RECRUITING

    Vandœuvre-lès-Nancy, 54519, France

  • Research Site

    RECRUITING

    Vannes, 56017, France

  • Research Site

    RECRUITING

    Villefranche-sur-Saône, 69655, France

  • Research Site

    RECRUITING

    Villeurbanne, 69100, France

  • Research Site

    NOT_YET_RECRUITING

    Berlin, 14089, Germany

  • Research Site

    NOT_YET_RECRUITING

    Dresden, 1127, Germany

  • Research Site

    RECRUITING

    Frankfurt am Main, 60488, Germany

  • Research Site

    NOT_YET_RECRUITING

    Frankfurt am Main, 65929, Germany

  • Research Site

    NOT_YET_RECRUITING

    Halle, 6120, Germany

  • Research Site

    NOT_YET_RECRUITING

    Hamburg, 20249, Germany

  • Research Site

    RECRUITING

    Hanover, 30161, Germany

  • Research Site

    NOT_YET_RECRUITING

    Hanover, 30171, Germany

  • Research Site

    NOT_YET_RECRUITING

    Hanover, 30629, Germany

  • Research Site

    NOT_YET_RECRUITING

    Heidelberg, 69115, Germany

  • Research Site

    NOT_YET_RECRUITING

    Kassel, 34125, Germany

  • Research Site

    NOT_YET_RECRUITING

    L Rrach, 79539, Germany

  • Research Site

    NOT_YET_RECRUITING

    Landshut, 84036, Germany

  • Research Site

    NOT_YET_RECRUITING

    M Nnerstadt, 97702, Germany

  • Research Site

    RECRUITING

    Magdeburg, 39120, Germany

  • Research Site

    NOT_YET_RECRUITING

    Neuss, 41462, Germany

  • Research Site

    NOT_YET_RECRUITING

    Schorndorf, 73614, Germany

  • Research Site

    NOT_YET_RECRUITING

    Wiesbaden, 65199, Germany